Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to osteoclast

cell that functions in the breakdown and resorption of bone tissue

Related Words

References in periodicals archive ?
has anti-bone resorption activity and suggest that its constituent, sanguiin H-6, can potentially be used for the prevention and treatment of bone diseases associated with excessive osteoclast formation and subsequent bone destruction.
Despite all patients with osteopetrosis having gene defects that affect osteoclast function and activity, most mutations result in normal or increased numbers of osteoclasts (albeit non- or only poorly-functional), a fact which may partially explain the observed high-bone mass phenotype.
Results showed that mean osteoclast count was significantly more in EDB group as compared to NG group, while no osteoclast was found on the non-appliance control side of both groups.
OP is class of bone diseases, with characteristic features such as osteoclast failure and defective bone resorption.
2] in its atomic and ionic properties and because they are both agonists of the CaR, so that Sr+2 may regulate mature osteoclast apoptosis directly via the CaR.
Osteocytes produce signals that affect both osteoblast and osteoclast activity, although the molecular signalling pathways involved are not well understood.
Recently, research has shown that the process of vascular calcification resembles the process of bone formation, involving bone forming cells, osteoblasts, and bone absorbing cells, osteoclasts.
Multinuclear giant osteoclast cells are formed by the differentiation of hematopoietic precursor cells, which shear a common progenitor with macrophages and dendritic cells [2].
MicroRNAs can reduce that forced labor by inhibiting osteoclast proteins and thus limiting the number of osteoclasts present.
Osteoblasts not only play a central role in bone formation by synthesizing several bone matrix proteins, but regulate osteoclast maturation through expression of soluble factors RANKL and M-CSF, resulting in bone resorption.
It was shown that isoflavonoid glabridin could inhibit osteoclast maturation.
Unlike traditional antiresorptive drugs like bisphosphonates, however, odanacatib does not interfere with the function of the entire osteoclast or reduce the number of osteoclasts.
RANKL promotes osteoclast differentiation and activation, and denosumab prevents RANKL from engaging the RANK receptor on osteoclasts and osteoclast precursors thereby reducing osteoclast mediated bone resorption and increasing bone density.
Cancer researchers, radiologists, oncologists, and other medical specialists from the US and Europe discuss bisphosphonates and novel therapeutic agents, such as RANKL inhibitors, Wnt signaling inhibitors, and ImiDs, as well as osteonecrosis of the jaw, mouse models, and the mechanisms of osteoclast activation and osteoblast suppression in multiple myeloma.